Global RNA Based Therapeutics Market Is Expected To Reach $24.07 Bn By 2032

Zion Market Research has published a new report titled “RNA Based Therapeutics Market by Technology (Enabled Technology and Enabling Technology), by Application (Kidney Diseases, Cardiovascular, Metabolic Disorders, Infectious Diseases, Oncology, and Others), and by End-User (Research, Diagnosis, Therapeutics, and Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032”. According to the report, the global RNA based therapeutics market was approximately USD 13.66 billion in 2023 and is predicted to grow to around USD 24.07 billion by 2032 with a compound annual growth rate (CAGR) of roughly 6.50% between 2024 and 2032.

Worldwide cancer prevalence is increasing rapidly. In 2018, cancer was the second leading death cause globally. There were nearly 18.1 million new cancer cases and 9.6 million deaths across the globe in the same year. With increasing cancer cases, there is a growing demand for selective target specific treatment options, such as RNA-based therapeutics. The rising preference for targeted therapy due to its fewer side effects over traditional therapy is driving the RNA based therapeutics market globally. Additionally, strategic partnerships and funding for research and development, increasing public-private investments, and growing government support and funding for research and development are likely to further boost the market growth.

Other factors contributing to the RNA based therapeutics market growth are technological advancements, such as RNAi interference technology, SMaRT technology and antisense technology, increasing geriatric population base, rising chronic disease burden, and growing healthcare spending. However, high research and development cost of RNA-based therapeutics may limit the global RNA based therapeutics market growth.

Browse the full “RNA Based Therapeutics Market by Technology (Enabled Technology and Enabling Technology), by Application (Kidney Diseases, Cardiovascular, Metabolic Disorders, Infectious Diseases, Oncology, and Others), and by End-User (Research, Diagnosis, Therapeutics, and Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032” Report at https://www.zionmarketresearch.com/report/rna-based-therapeutics-market

The global RNA based therapeutics market is fragments based on technology, application, and end-user. Based on technology, the market includes enabling technologies and enabled technologies. Enabling technology segment is sub-categorized into labeling, microarrays, linear amplification, purification, inhibition, and qRT-PCR. The enabled technology segment is sub-categorized into RNA Interference (RNAi) technologies (microRNA and small interfering RNA) and RNA antisense technologies.

The enabled technology segment accounted for the largest share of the global RNA based therapeutics market in 2018, owing to its potential use in therapeutic applications. RNA Interference (RNAi) technology dominated the global market in 2018, owing to the ongoing research and development activities conducted by major manufacturers in this field.

Based on application, the market includes kidney diseases, cardiovascular, metabolic disorders, infectious diseases, oncology, and others. The oncology segment held the largest share of the global RNA based therapeutics market in 2018, owing to the increasing cancer prevalence across the globe, which has led to major manufacturers’ focus on therapeutic drug development for cancer and infectious diseases.

Therapeutics, research, diagnostics, and others comprise the end-user segment of the RNA based therapeutics market. The research segment dominated the global RNA based therapeutics market in 2018 and is expected to retain its leading position over the forecast time period as well.

North America dominated the global RNA based therapeutics market in 2018 with a revenue share of about 40%. The presence of key market players, increasing investments in RNA-based therapeutics research, favorable government funding policies, availability of developed research infrastructure, advancements made in RNA platform technologies are driving the North American RNA based therapeutics market growth. The Asia Pacific RNA based therapeutics market is expected to offer several growth opportunities to the major players.

RNA Based Therapeutics Market: Competitive Analysis

The global RNA based therapeutics market is led by players like:

• Quark Pharmaceuticals
• Alnylam Pharmaceuticals
• Dicerna Pharmaceuticals
• Tekmira Pharmaceuticals
• Benitec Biopharma
• Genzyme Corporation
• Ionis Pharmaceuticals
• Silence Therapeutics
• Cenix BioScience
• Sirnaomics

This report segments the global RNA based therapeutics market into:

Global RNA Based Therapeutics Market: By Technology

• Enabling Technology
  • Microarrays
  • Labeling
  • Purification
  • Linear Amplification
  • qRT-PCR
  • Inhibition
• Enabled Technology
  • RNA Interference (RNAi) Technologies
    • Small Interfering RNA (siRNA)
    • MicroRNA (miRNA)
  • RNA Antisense Technologies

Global RNA Based Therapeutics Market: By Application

• Cardiovascular
• Kidney Diseases
• Oncology
• Infectious Diseases
• Metabolic Disorders
• Others

Global RNA Based Therapeutics Market: By End-User

• Research
• Therapeutics
• Diagnosis
• Others

Global RNA Based Therapeutics Market: By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com